Japan· JP-1124009F2025
ブロチゾラム
A brotizolam product containing ブロチゾラム, registered in Japan by 日本ベーリンガーインゲルハイム, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Brotizolam is registered in 5 of 19 countries.
Countries holding a registration under ATC N05CD09 (brotizolam), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 2 of them publish a price we can compare per daily dose
Brotizolam · ATC N05CD09
5 / 19 countries
- Belgiumprice
- Germany
- Japan
- Netherlands
- Spainprice
Price per daily dose
What a daily dose of brotizolam costs, country by country.
Normalised to the WHO defined daily dose (0.25 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Brotizolam · price per daily dose (0.25 mg)
USD · FX 28 Sept 2026
- ES Spain$0.17
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ブロチゾラム
- Manufacturer
- 日本ベーリンガーインゲルハイム
- Country
- Japan (JP)
- ATC code
- N05CD09
- ATC class
- Brotizolam
- Defined daily dose
- 0.25 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N05CD09
Brotizolam, as other registers publish it.
- BelgiumBrotizolam Amdipharm 0.25 mgAmdipharm
- GermanyLendorminBoehringer Ingelheim Pharma Gmbh & Co. Kg
- BelgiumLendormin 0.25 mgImpexeco
- BelgiumLendormin 0.25 mgBoehringer Ingelheim
- BelgiumLendormin 0.25 mgImpexeco
- NetherlandsLendormin, tabletten 0,25 mgBoehringer Ingelheim B.V.
- SpainSINTONAL 0,25 mg comprimidosBoehringer Ingelheim Espana S.A.
- Japanブロチゾラム日本ベーリンガーインゲルハイム
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d39edece-0508-46bb-a581-a3b12591ff54 GET /v1/drugs/d39edece-0508-46bb-a581-a3b12591ff54?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "０．２５ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1124009F2025",
"category": "内用薬",
"price_yen": 10.8,
"generic_name": "ブロチゾラム",
"product_name_jp": null,
"therapeutic_class": "1124",
"transitional_expiry": null
}See everything about brotizolam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.